Page last updated: 2024-08-24

dexmedetomidine and Chemical and Drug Induced Liver Injury, Chronic

dexmedetomidine has been researched along with Chemical and Drug Induced Liver Injury, Chronic in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Li, D; Li, J; Li, Q; Liu, W; Qian, J; Wang, J; Wu, D1
Bo, L; Hu, B; Li, J; Luo, Y; Wang, H; Wang, J; Zou, Y1

Other Studies

2 other study(ies) available for dexmedetomidine and Chemical and Drug Induced Liver Injury, Chronic

ArticleYear
Dexmedetomidine attenuates acute stress-induced liver injury in rats by regulating the miR-34a-5p/ROS/JNK/p38 signaling pathway.
    The Journal of toxicological sciences, 2022, Volume: 47, Issue:5

    Topics: Adenosine Monophosphate; Animals; Apoptosis; bcl-2-Associated X Protein; Caspase 3; Chemical and Drug Induced Liver Injury, Chronic; Cyclooxygenase 2; Cytochromes c; Dexmedetomidine; Glutathione; MAP Kinase Signaling System; MicroRNAs; Oxidative Stress; Proto-Oncogene Proteins c-bcl-2; Rats; Reactive Oxygen Species; Superoxide Dismutase

2022
Dexmedetomidine premedication attenuates concanavalin A-induced hepatitis in mice.
    The Journal of toxicological sciences, 2014, Volume: 39, Issue:5

    Topics: Adrenergic alpha-2 Receptor Agonists; Animals; CD4-Positive T-Lymphocytes; Chemical and Drug Induced Liver Injury, Chronic; Chemokine CXCL10; Concanavalin A; Cytokines; Dexmedetomidine; Inflammation Mediators; Liver; Male; Mice; Mice, Inbred C57BL; NF-kappa B; Phosphorylation

2014